Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Enhancing quality and improving outcomes: patient-first approach in Fabry disease

Half-life extension with Fc-fusion

Watch a 3-minute animated video explaining the mechanism of action (MOA) for extended half-life Fc-fusion factor replacement therapies.

Approach for patients with coronary artery disease (CAD): focus on LDL-C control

Approach for patients with coronary artery disease (CAD): focus on LDL-C control

Approach for patients with coronary artery disease (CAD): focus on LDL-C control

Approach for patients with coronary artery disease (CAD): focus on LDL-C control

Phillip Moshe

Schneider Children’s Medical Center of Israel
Petah Tikva, Israel

Hood Korey

Stanford University School of Medicine 
Palo Alto, California, USA

Gitelman Stephen

 University of California School of Medicine, San Francisco, USA

Islet Autoantibodies in T1D

The number, type, and titer of islet autoantibodies detected in T1D screening tests provide valuable information about potential progression to clinical T1D. 

Monitoring Individuals with IAb Positive Status

Explore how clinical outcomes are impacted by screening and monitoring

Exploring the Etiology of Autoimmune Type 1 Diabetes

Overview of the factors playing a role in the etiology of T1D.